BLOG

Stem Cell Therapy Risks in Japan: Questions to Ask Your Doctor

Published 2026.10.15 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are exploring regenerative medicine in Japan, you have probably read a lot about what stem cell treatments might offer. Far fewer articles explain what to ask about risks and side effects. This guide is written for international patients, expatriates and medical travelers who want a clearer checklist before booking a consultation about adipose-derived stem cell therapy at Grand Green Osaka Umekita Clinic or any other facility.

The short answer: every medical treatment carries uncertainty

No treatment is free of risk, and regenerative medicine is no exception. Adipose-derived stem cell therapy is a self-pay (non-insured) option in Japan, and its outcomes differ from person to person. Whether it is appropriate for you can only be judged by a physician after an in-person or remote consultation. A good consultation should cover the possible benefits, the possible downsides, the alternatives, and the option of not proceeding at all.

Standard care for your condition should not be set aside because of something you read online. Stem cell therapy is generally discussed as an additional option to talk through with your own doctors, not as a replacement for established treatment.

How the treatment works, and where risks can arise

In this approach, a small amount of fat tissue is collected from your own body under local anesthesia. Mesenchymal stem cells contained in that tissue are then cultured and expanded at a specialized facility, and the cultured cells are returned to you by intravenous infusion. Because the cells come from you, the risk of rejection is considered lower than with donor cells, but that does not mean risk is absent.

Each step has its own points to discuss with your doctor:

Fat collection: bruising, soreness, bleeding, infection at the collection site, or a reaction to local anesthesia are possible with any minor procedure.
Cell culture: the quality control of the culture facility, and the handling of cells during transport, matter for avoiding contamination.
Infusion: reactions during or after an intravenous drip, such as fever, chills, a rash or discomfort at the needle site, have been described in the medical literature on cell infusions.
Longer term: because research is still evolving, long-term outcomes are not fully established, and you may be asked about follow-up.

What published research does and does not tell us

Reviews of clinical studies on mesenchymal stem cells, searchable on PubMed, generally report that serious adverse events were uncommon in the trials examined, while minor and temporary reactions were more frequent. However, those trials differ widely in cell source, dose, route of administration and patient population, and many were small or short in duration. Findings from one study should not be generalized to every clinic or every patient.

It is also reported that infused mesenchymal stem cells may travel through the bloodstream and gather near sites of inflammation or damage, and that they may release anti-inflammatory substances and growth factors. These are research observations about how cells behave, not promises about what any individual will experience. A trustworthy clinic will keep that distinction clear.

How Japan regulates regenerative medicine

In Japan, clinics that provide this type of treatment operate under the Act on the Safety of Regenerative Medicine. Under this framework, a facility prepares a regenerative medicine provision plan, which is reviewed by a certified committee and then submitted to the Ministry of Health, Labour and Welfare. Cell processing is expected to take place at a registered or approved facility.

This system is designed to add oversight, but it is not a statement that a particular treatment is effective for your condition. Treatments offered this way are not covered by national health insurance, and they are not the same as drugs approved for a specific disease. It is reasonable to ask the clinic which plan applies to the treatment you are considering and how the plan is described to patients.

Questions to bring to your consultation

Writing your questions down beforehand helps, especially when you are speaking in a second language or through an interpreter. Consider asking the following:

Is this treatment suitable for my medical history, current medications and any existing conditions?
What are the known risks and side effects of each step, and what happens if one occurs after I return home?
Are there reasons I might be advised not to proceed, such as pregnancy, infection, or a history of cancer?
What is the total cost, what is included, and what would be charged separately? Costs should be confirmed directly with the clinic.
How many visits are needed, how long does the culture period last, and how should I plan travel dates around it?
What follow-up is available, and can my doctor in my home country receive a summary of my treatment?

If anything in the explanation is unclear, you can ask for it to be repeated or provided in writing. You are free to take time to decide.

Planning as an international patient in Osaka

Grand Green Osaka Umekita Clinic is located in Umeda, Osaka, and offers information pages for international patients in multiple languages, so you can review the general flow of treatment before you get in touch. Because the process involves a collection visit, a culture period and a later infusion visit, it helps to think about schedule, accommodation and how you will reach the clinic if you have symptoms after you leave.

Bring your recent test results, a list of medications and, if possible, a short summary from your regular physician. Sharing a complete health picture allows the doctor to assess risk more accurately.

Summary

Adipose-derived stem cell therapy in Japan is a self-pay treatment provided under a regulatory framework, and it carries risks and uncertainties like any other medical procedure. Published research offers useful context but cannot predict your personal outcome. The most helpful step is a consultation in which a physician reviews your history, explains risks, side effects, costs and alternatives, and answers your questions clearly. Eligibility, risks and expected course must always be confirmed with a doctor before any decision is made.

Questions Before You Decide

Doctor consultationSuitability is judged by a physician
Risks and side effectsAsk about each step
Japanese regulationSelf-pay, under a provision plan
Costs and follow-upConfirm with the clinic

This figure is a conceptual summary of the article content

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›